Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...
Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more ...
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...
Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.
An effort two decades in the making, Vertex Pharmaceuticals Inc.’s suzetrigine gained U.S. FDA approval as the first drug targeting the NaV1.8 pain signal. Branded Journavx, the oral small molecule is ...